Koa Shoji Holdings (9273) · FactRestated
Absorption-type merger of コーア製薬株式会社 and コーアバイオテックベイ株式会社
First written in FY2023-Q1. 1 of 2 entries say "Restated". Latest entry: FY2023-Q2.
2entries
2years
0from disclosures
How it moved
Same theme, other companies
Merger by absorption of コーア製薬株式会社 and コーアバイオテックベイ株式会社A theme 1 companies write about · 0 as a headwind · 0 as a tailwind
No other company in this theme has enough history to compare yet.
Full recordFilings, disclosures and news, newest first
- FY2023-Q2RestatedAnnual report
「During the first quarter, コーア製薬株式会社, which had been a consolidated subsidiary of the Company, ceased to exist effective 1 July 2022 through an absorption-type merger in which コーアバイオテックベイ株式会社, also a consolidated subsidiary of the Company, remained as the surviving company.」
It reconfirms the absorption-type merger of コーア製薬株式会社 and コーアバイオテックベイ株式会社 effective 1 July 2022. - FY2023-Q1First statedAnnual report
「The subsidiary コーア製薬株式会社 was absorbed into コーアバイオテックベイ株式会社, which remained as the surviving company, and ceased to exist on 1 July 2022.」
It states that, effective 1 July 2022, コーア製薬株式会社 ceased to exist through an absorption-type merger in which コーアバイオテックベイ株式会社 remained as the surviving company.